DiMarco Kathryn 4
4 · Organon & Co. · Filed Apr 3, 2024
Insider Transaction Report
Form 4
DiMarco Kathryn
Corporate Controller
Transactions
- Exercise/Conversion
Common Stock
2024-03-31+4,294→ 16,031 total - Tax Payment
Common Stock
2024-03-31$18.80/sh−1,471$27,655→ 14,560 total - Exercise/Conversion
Common Stock
2024-03-31+8,503→ 23,063 total - Tax Payment
Common Stock
2024-03-31$18.80/sh−2,913$54,764→ 20,150 total - Exercise/Conversion
Restricted Stock Units
2024-03-31−4,294→ 4,294 total→ Common Stock (4,294 underlying) - Exercise/Conversion
Restricted Stock Units
2024-03-31−8,503→ 17,007 total→ Common Stock (8,503 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit converts into one share of Organon & Co. ("Organon") common stock.
- [F2]The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon common stock for each RSU. On each of March 31, 2023, and March 31, 2024, one-third of the RSUs vested, with the remaining RSUs to vest on March 31, 2025.
- [F3]On March 31, 2024, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2025 and March 31, 2026.